alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<partyblock><br><br><div align="center"><b><font size="+1">TAM Medical Supply Corp., as Assignee of Reyes, Salamon 1, Appellant,<br><br>against<br><br>MVAIC, Respondent.</font></b></div><br><br><p>The Rybak Firm, PLLC (Damin J. Toell of counsel), for appellant.Marshall &amp; Marshall, PLLC (Jeffrey Kadushin of counsel), for respondent.</p><p>Appeal from a judgment of the Civil Court of the City of New York, Kings County (Richard J. Montelione, J.), entered November 22, 2016. The judgment, entered pursuant to a decision of the same court dated June 12, 2016, after a nonjury trial, dismissed the complaint.</p><p>ORDERED that, on the court's own motion, the notice of appeal from the decision dated June 12, 2016 is deemed a premature notice of appeal from the judgment entered November 22, 2016 (<i>see</i> CPLR 5520 [c]); and it is further,</p><p>ORDERED that the judgment is affirmed, with $25 costs.</p><p>In this action by a provider to recover assigned first-party no-fault benefits, the sole issue for trial (<i>see</i> CPLR 3212 [g]) was whether the verification requested by defendant Motor Vehicle Accident Indemnification Corporation (sued herein as MVAIC) had been provided. The only witness at trial was an employee of MVAIC, who testified that MVAIC had not received the requested verification. The Civil Court found the testimony to be credible and entered judgment dismissing the complaint.</p><p>Plaintiff's sole argument on appeal is that the testimony by MVAIC's witness as to whether MVAIC received the requested verification was hearsay because the witness began working for MVAIC more than one year after the accident. Assuming that plaintiff preserved this issue for appellate review, we find that the testimony was sufficient to establish that the verification which MVAIC had requested had not been received by MVAIC.</p><p>The witness testified that MVAIC's practices and procedures included the maintaining of a manual which set forth, among other things, MVAIC's practices and procedures regarding the receipt of mail, as well as enumerating when, and how, MVAIC's practices and procedures were <font color="FF0000">[*2]</font>changed and stating the period of time during which each set of practices and procedures were in effect. The witness further testified that, as part of his training, he relied upon MVAIC's manual and that the practices and procedures utilized by MVAIC when his employment began were identical to the practices and procedures in effect when the accident occurred and that they did not change prior to the start of his employment. Furthermore, in accordance with MVAIC's practices and procedures, he searched MVAIC's records and the requested verification had not been received by MVAIC. In light of the foregoing, the judgment is affirmed.</p><p>PESCE, P.J., WESTON and ALIOTTA, JJ., concur.</p><br>ENTER:<br>Paul Kenny<br>Chief Clerk<br>Decision Date: July 12, 2019<br><br><div align="center"><form method="LINK" action="../../slipidx/at_2_idxtable.shtml"><input type="submit" value="Return to Decision List"></form></div></partyblock>
[Federal Register Volume 89, Number 15 (Tuesday, January 23, 2024)]
[Notices]
[Page 4301]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01260]



[[Page 4301]]

=======================================================================
-----------------------------------------------------------------------

FEDERAL FINANCIAL INSTITUTIONS EXAMINATION COUNCIL

[Docket No. AS24-02]


Appraisal Subcommittee Notice of Meeting

AGENCY: Appraisal Subcommittee of the Federal Financial Institutions 
Examination Council.

ACTION: Notice of special meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with Section 1104(b) of Title XI of the 
Financial Institutions Reform, Recovery, and Enforcement Act of 1989, 
as amended, notice is hereby given that the Appraisal Subcommittee 
(ASC) met for a Special Meeting on this date.
    Location: Virtual meeting via Webex.
    Date: January 17, 2024.
    Time: 10:38 a.m. ET.

Action and Discussion Items

ASC Grants Handbook (revised)
ASC Fiscal Year 2024 Notice of Funding Availability (State Grant)

    The ASC convened a Special Meeting to vote on the above-referenced 
items. The vote for each item passed 7-0.

James R. Park,
Executive Director.
[FR Doc. 2024-01260 Filed 1-22-24; 8:45 am]
BILLING CODE 6700-01-P
<PAGE>

                                                                     EXHIBIT 7.1
                                                                TO ANNUAL REPORT
                                                                    ON FORM 20-F

    STATEMENT EXPLAINING HOW CERTAIN RATIOS WERE CALCULATED IN ANNUAL REPORT

1.    The operating ratio of Guangshen Railway is the percentage of its total
      railway operating expenses in 2004 (in the amount of RMB2,241.8 million,
      as opposed to RMB1,755.9 million in 2003) to Guangshen Railway's total
      railway revenues in 2004 (in the amount of RMB2,871.5 million, as opposed
      to RMB2,316.6 million in 2003).

2.    Guangshen Railway's total railway operating income ratio is 1 minus the
      operating ratio.

3.    Guangshen Railway's overall operating income ratio is 1 minus the
      percentage of its operating costs in 2004 (in the amount of RMB2,408.0
      million, as opposed to RMB1,905.5 million in 2003) to the business
      revenues in 2004 (in the amount of RMB3,038.1 million, as opposed to
      RMB2,468.2 million in 2003).
### Revised EGU GHG NSPS proposal **Peter Tsirigotis** to

: Mancini, Dom, Nathan_J._Frey
Cc : "W ayland, Bob", "Culligan, Kevin", "Johnson, Mary", "Tsirigotis, Peter"

From: Peter Tsirigotis/RTP/USEPA/US To: "Mancini, Dom" <dmancini@omb.eop.gov>, Nathan_J._Frey@omb.eop.gov Cc: "W ayland, Bob" <wayland.robertj@epa.gov>, "Culligan, Kevin" <culligan.kevin@epa.gov>, "Johnson, Mary" <Johnson.Mary@epamail.e

Peter" <Tsirigotis.Peter@ep amail.epa.gov>

EO 12866 EGU GHG NSPS proposal FR notice 02_28_12.docx

EO 12866 EGU GHG NSPS preamble_02_28_12_v_02_08_12 redline.docx 

### Hi Dom and Nathan. Attached are two files of the revised version of the proposal, one file comparing this revision to what you already have with redline/strikeout, and one file that is clean. Feel free to call Bob, Kevin, or me to discuss.
#### James JOHNSON, Plaintiff-Appellant, v. NEW YORK PRESBYTERIAN HOSPITAL, Herbert Pardes, Pres., Defendants-Appellees.

No. 02-7562.

United States Court of Appeals, Second Circuit.

Jan. 29, 2003.

James Johnson, Maspeth, NY, for Appellant, pro se.

Barbara E. Hoey, Kelley, Drye & Warren, New York, NY, for Appellees.

PRESENT: NEWMAN, KATZMANN, and RAGGI, Circuit Judges.

SUMMARY ORDER

UPON DUE CONSIDERATION, IT IS HEREBY . ORDERED, ADJUDGED AND DECREED that the judgment of the District Court is AFFIRMED.

In September 2000, James Johnson filed a complaint against New York Presbyterian Hospital and Herbert Pardes, Presi*26dent of the Hospital, alleging that they retaliated against him in a discriminatory fashion in violation of Title VII of the Civil Rights Act, 42 U.S.C. § 2000e, Section 504 of the Rehabilitation Act, 29 U.S.C. § 701, and the Americans with Disabilities Act, 42 U.S.C. § 12112. We have considered all of the appellant’s arguments. Upon review of the record and the district court’s memorandum opinion and order dismissing Johnson’s complaint, we affirm for substantially the reasons set forth in the district court’s memorandum opinion and order. *See Johnson v. New York Presbyterian Hosp.,*No. 00 Civ. 6776, 2001 WL 829868 (S.D.N.Y. July 20, 2001).
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 98-2745

MARVIN CRIGGER, Plaintiff - Appellant, versus TRUSTEES OF THE UNITED MINE WORKERS HEALTH & RETIREMENT FUNDS, Defendant - Appellee. Appeal from the United States District Court for the Western District of Virginia, at Abingdon. James P. Jones, District Judge. (CA-98-79) Submitted: April 30, 1999 Decided: May 21, 1999 Before WILKINS and TRAXLER, Circuit Judges, and HALL, Senior Circuit Judge. Affirmed by unpublished per curiam opinion. John M. Lamie, BROWNING, LAMIE & SHARP, P.C., Abingdon, Virginia, for Appellant. Glenda S. Finch, Deputy General Counsel, Christopher F. Clarke, Assistant General Counsel, UMWA HEALTH & RETIREMENT FUNDS, Washington, D.C., for Appellee. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM: Marvin Crigger appeals the district court’s order granting the Appellee’s motion for summary judgment in this action arising under Title I of the Employee Retirement Income Security Act of 1974, 29 U.S.C.A. §§ 1001-1168 (West 1994 & Supp. 1998) (“ERISA”). We have reviewed the record and the district court’s opinion and find no reversible error. Accordingly, we affirm on the reasoning of the district court. See Crigger v. Trustees UMWA , No. CA-98-79 (W.D. Va. Oct. 29, 1998). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of In Veritas Medical Diagnostics,  Inc.
(the  "Company")  on Form 10-QSB for the  quarter  ended April 30, 2006 as filed
with the Securities and Exchange  Commission on the date hereof (the  "Report"),
I, Martin E. Thorp, Chief Financial Officer of the Company, certify, pursuant to
18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities and Exchange Act of 1934; and

(2) The  information  contained in the Report fairly  presents,  in all material
respects, the financial condition and result of operations of the Company.

A signed  original of this  written  statement  required by Section 906 has been
provided  to In Veritas  Medical  Diagnostics,  Inc.  and will be retained by In
Veritas Medical  Diagnostics,  Inc. and furnished to the Securities and Exchange
Commission or its staff upon request.




June 19, 2006                                       /s/ Martin E. Thorp
                                                     ---------------------------
                                                     Martin E. Thorp
                                                     Chief Financial Officer
----

            DECISION OF THE EUROPEAN PARLIAMENT         

of 27 April 2006         

on the discharge for the implementation of the budget of the European Medicines Agency for the financial year 2004

(2006/836/EC)

THE EUROPEAN PARLIAMENT,

The President

Josep BORRELL FONTELLES            

The Secretary-General

Julian PRIESTLEY            

----

(1)OJ C 269, 28.10.2005, p. 17.

(2)OJ C 332, 28.12.2005, p. 8.

(3)OJ L 248, 16.9.2002, p. 1.

(4)OJ L 136, 30.4.2004, p. 1.

(5)OJ L 357, 31.12.2002, p. 72. Regulation as amended by Regulation (EC, Euratom) No 1261/2005 (OJ L 201, 2.8.2005, p. 3).

----
Exhibit 32.2





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ENACTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002








In connection with the Quarterly Report of Global Entertainment Holdings,  (the "Company") on Form 10-Q for the period ending June 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Stanley Weiner, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as enacted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:




(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.








/s/ Stanley Weiner


Stanley Weiner,


Chief Financial Officer





August 20, 2010
#### John ALLEN, Plaintiff-Appellant, v. Ron ANGELONE; Gene Johnson, D.O.C. Operator; Richard Young, Former Regional Director; Larry Huffman, Regional Director; Paige True, Former Warden, Red Onion State Prison; J. Armentrout, Assistant Warden, Red Onion State Prison; Daniel Braxton, Warden, Red Onion State Prison; S. Mullins, Mailroom Staff; T. Pease, Mailroom Staff, Red Onion State Prison, Defendants-Appellees.

No. 02-7678.

United States Court of Appeals, Fourth Circuit.

Submitted Jan. 16, 2003.

Decided Jan. 27, 2003.

John Allen, Appellant Pro Se.

Before WILLIAMS, KING, and GREGORY, Circuit Judges.

Dismissed by unpublished PER CURIAM opinion.

PER CURIAM.

John Allen seeks to appeal the district court’s order dismissing some but not all defendants in his 42 U.S.C. § 1983 (2000) action. This court may exercise jurisdiction only over final orders, 28 U.S.C. § 1291 (2000), and certain interlocutory and collateral orders, 28 U.S.C. § 1292 (2000); Fed.R.Civ.P. 54(b); *Cohen v. Beneficial Indus. Loan Corp.,*337 U.S. 541, 69 S.Ct. 1221, 93 L.Ed. 1528 (1949). The order Allen seeks to appeal is neither a final order nor an appealable interlocutory or collateral order. Accordingly, we dismiss the appeal for lack of jurisdiction. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*DISMISSED.*
Exhibit 32.1


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of LitFunding Corp. a Nevada corporation
(the "Company") on Form 10-QSB for the period ending June 30, 2003, as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
Morton Reed, Chief Executive Officer of the Company, certifies to the best of
his knowledge, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of
the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company.

A signed original of this written statement required by Section 906 has been
provided to LitFunding Corp. and will be retained by LitFunding Corp. and
furnished to the Securities and Exchange Commission or its staff upon request.


/s/ Morton Reed
--------------------------
Morton Reed
Chief Executive Officer


September 15, 2004
Exhibit 10.3


 




	
  

  	
  [LOGO]

  






 















	
  

  	
  [LOGO]

  






 















	
  

  	
  [LOGO]

  






 















	
  

  	
  [LOGO]

  






 















	
  

  	
  [LOGO]

  






 















	
  

  	
  [LOGO]

  






 















	
  

  	
  [LOGO]
EXHIBIT 8.1
 List of Subsidiaries of Guangshen Railway Company Limited
  Country of
    
    Percentage of Interest heldName
    
    Incorporation
    
    by the CompanyGuangshen Railway Dongqun Trade and Commerce Service
Company
    
    PRC
    
    
    100
    %Shenzhen Fu Yuan Enterprise Development Company Limited
    
    PRC
    
    
    100
    %Shenzhen Guangshen Railway Travel Service Ltd.
    
    PRC
    
    
    100
    %Shenzhen Pinghu Qun Yi Railway Store Loading and Unloading
Company Limited
    
    PRC
    
    
    55
    %Dongguan Changsheng Enterprise Company Limited
    
    PRC
    
    
    51
    %Shenzhen Railway Station Passenger Services Company Limited
    
    PRC
    
    
    100
    %Guangzhou Tielian Economy Development Company Limited
    
    PRC
    
    
    50.5
    %Shenzhen Nantie Construction Supervision Company
    
    PRC
    
    
    76.66
    %Guangzhou Railway Huangpu Service Company Limited
    
    PRC
    
    
    100
    %Shenzhen Guangshen Railway Economic and Trade Enterprise Company Limited
    
    PRC
    
    
    100
    %Shenzhen Railway Property Management Company Limited
    
    PRC
    
    
    100
    %Guangzhou Dongqun Advertising Company Limited
    
    PRC
    
    
    100
    %Shenzhen Shenhuasheng Storage and Transportation Company
Limited
    
    PRC
    
    
    100
    %
**Exhibit32.1**

 

 

**AFFINITYGROUP, INC.**

 

**STATEMENTPURSUANT TO 18 U.S.C. SECTION 1350**

 

 

 

I, Michael A. Schneider, President and ChiefExecutive Officer of Affinity Group, Inc., a Delaware corporation (the “Company”),hereby certify as follows:

 

1.                                       This statementis provided pursuant to 18 U.S.C. Section 1350 in connection with the Company’sAnnual Report on Form 10-K for the fiscal year ended December 31, 2004 (the “PeriodicReport”);

 

2.                                       The PeriodicReport fully complies with the requirements of section 13(a) and 15(d) of theSecurities Exchange Act of 1934, as amended; and

 

3.                                       The informationcontained in the Periodic Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company as of the datesand for the periods indicated therein.

 

 
| Date: March 4, 2005 |                                   |
|---------------------|----------------------------------------|
|                |                                   |
|                | /s/ Michael A. Schneider               |
|                | Michael A. Schneider                   |
|                | President  and Chief Executive Officer |

 

 

 

 

----
[Federal Register Volume 89, Number 10 (Tuesday, January 16, 2024)]
[Notices]
[Page 2624]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00688]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2024-N-0065]


Notice of Approval of Product Under Voucher: Material Threat 
Medical Countermeasure Priority Review Voucher; FABHALTA

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
approval of a product redeeming a material threat medical 
countermeasure (MCM) priority review voucher. The Federal Food, Drug, 
and Cosmetic Act (FD&C Act) authorizes FDA to award priority review 
vouchers to sponsors of approved material threat MCM product 
applications that meet certain criteria. FDA is required to publish 
notice of the issuance of material threat MCM priority review vouchers 
as well as the approval of products redeeming a voucher. FDA has 
determined that FABHALTA (iptacopan) capsules, approved December 5, 
2023, meets the redemption criteria.

FOR FURTHER INFORMATION CONTACT: Cathryn Lee, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Silver Spring, MD 20993-0002, 301-796-1394, email: 
<a href="/cdn-cgi/l/email-protection#ffbc9e8b978d8691d1b39a9abf999b9ed197978cd1989089"><span class="__cf_email__" data-cfemail="692a081d011b100747250c0c290f0d084701011a470e061f">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: Under section 565A of the FD&C Act (21 
U.S.C. 360bbb-4a) FDA will report the issuance of material threat MCM 
priority review vouchers and the approval of products for which a 
voucher was redeemed. FDA has determined that the application for 
FABHALTA (iptacopan) capsules, approved December 5, 2023, meets the 
redemption criteria.
    For further information about the material threat MCM Priority 
Review Voucher Program and for a link to the full text of section 565A 
of the FD&C Act, go to https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/21st-century-cures-act-mcm-related-cures-provisions#prv. For further information about 
FABHALTA (iptacopan) capsules go to the ``Drugs@FDA'' website at http://www.accessdata.fda.gov/scripts/cder/daf/.

    Dated: January 10, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024-00688 Filed 1-12-24; 8:45 am]
BILLING CODE 4164-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
104TH CONGRESS

1ST SESSION S. 172

AN ACT

To authorize the Secretary of Transportation to issue a

certificate of documentation for the vessel L. R. BEATTIE.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. AUTHORIZATION OF CERTIFICATE OF DOCU4 MENTATION.

5 Notwithstanding sections 12106, 12107, and 12108

6 of title 46, United States Code, and section 27 of the Mer7 chant Marine Act, 1920 (46 App. U.S.C. 883), as applica8 ble on the date of enactment of this Act, the Secretary

9 of Transportation may issue a certificate of documentation

10 for the vessel L. R. BEATTIE, United States official

11 number 904161.

Passed the Senate July 29, 1996.

Attest:

Secretary.
104TH CONGRESS

1ST SESSION S. 172

AN ACT

To authorize the Secretary of Transportation to

L. R. BEATTIE.issue a certificate of documentation for the vessel
##### 



Exhibit
12
 CONEXANT SYSTEMS, INC.
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
(in thousands, except ratios)
 Fiscal Years2007
    
    
    2006
    
    
    2005
    
    
    2004
    
    
    2003Income (loss) before income taxes
    
    $
    (398,085
    )
    
    $
    (119,699
    )
    
    $
    (173,668
    )
    
    $
    (300,916
    )
    
    $
    23,433Add: loss (income) from equity
method investments
    
    
    (51,182
    )
    
    
    8,164
    
    
    
    10,642
    
    
    
    (14,422
    )
    
    
    3,119Add: fixed charges-Interest expense, including amortization
of debt issuance costs
    
    
    48,986
    
    
    
    38,130
    
    
    
    33,691
    
    
    
    30,708
    
    
    
    28,120Interest element of rent expense
    
    
    655
    
    
    
    789
    
    
    
    1,055
    
    
    
    1,065
    
    
    
    840Total fixed charges
    
    
    49,641
    
    
    
    38,919
    
    
    
    34,746
    
    
    
    31,773
    
    
    
    28,960Total earnings (losses) available
for fixed charges
    
    
    (399,626
    )
    
    $
    (72,616
    )
    
    $
    (128,280
    )
    
    $
    (283,565
    )
    
    $
    55,512Ratio of earnings to fixed charges (1)
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    1.9
 
 (1)
    
    For purposes of calculating this ratio, earnings consist of income (loss) from continuing
operations before (i) income taxes, (ii) income (loss) from equity method investments and
(iii) fixed charges. Fixed charges consist of interest expense, including amortization of
debt issuance costs, and the portion of rent expense which we believe is representative of the
interest component of rental expense. Earnings were insufficient to cover fixed charges by
$449.3 million, $111.5 million, $163.0 million and $315.3 million for fiscal years 2007, 2006,
2005 and 2004 respectively.